Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2006

Published by: Decision Resources

Published: Jun. 26, 2006 - 31 Pages

Price reduced due to age.

Table of Contents


Contents Introduction

United States

Medicare Prescription Drug Benefit

Teething Problems

Enrollment and Public Perceptions

Intense Competition Among Insurers

Controversy over Drug Prices

Prescribing Restrictions

No Bonanza for the Pharmaceutical Industry

Medicaid Budget Cuts

Drug Importation in Decline

Investigation of Authorized Generics

Pfizer Faces Off-Label Marketing Lawsuit

France

Mixed Results for Government’s Medical Control Strategy

Continued Efforts to Promote Greater Use of Generics

Germany

Increased Pharmaceutical Spending Despite Lower Prices

Tough New Cost-Containment Measures

More-Aggressive Reference Prices

Price Freeze

Price Cuts on Off-Patent Medicines

An End to Rebates in Kind

Daily Cost of Therapy Limits for Frequently Prescribed
Medicines

New Innovation Hurdle

Italy

Prices in Decline

Spain

Continued Price Cuts Help Slow Spending

Slow Progress for New Medicines Law

Plans to Reform Inspection Visa Process

United Kingdom

Changes at the National Institute for Health and Clinical Excellence

Approval for Expanded Use of Statins

Japan

Tough New Price Reforms Unveiled

Sharp Cuts in Latest Price Revision

Repricing of High-Selling Drugs

Price Cuts for Long-Listed Drugs

More Generous Price Premiums for Innovation

Proposals to Restrict the Use of the Foreign Price Adjustment Rule

Lingering Threat of Further Reforms

Potential for Vigorous Growth in the Generics Market

Outlook and Implications for the Pharmaceutical Industry

Abstract

The first quarter of 2006 witnessed several significant developments in the pharmaceutical pricing and reimbursement environment in the major pharmaceutical markets. How has the launch of the new Medicare prescription drug benefit been received? What cost-savings efforts are being pursued in Europe? What will pending changes to the operation of the U.K. National Institute for Health and Clinical Excellence (NICE) bring? Japan’s latest biennial price reform was the most aggressive in several years--what’s next for this country’s pricing system? In this report, we review major events in the first quarter of 2006 in the pharmaceutical pricing, reimbursement, and prescribing environment in the aforementioned pharmaceutical markets. We focus on measures that health care payers are using to curb their drug expenditures and to improve patient access to medications. We conclude with an assessment of the outlook and implications for the pharmaceutical industry.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008